US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
5 deals · US$1.5bndisclosed · Nuclear energy · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Jul 2026 | Standard Nuclear | – | – | IPO | Announced | 150.0 | Nuclear energy+2 | William Blair (lead manager)Orrick (issuer)BofA Securities (lead manager)Goldman Sachs (lead manager)Barclays (lead manager)UBS (lead manager)Evercore (lead manager)RBC Capital Markets (lead manager)Stifel (lead manager)Davis Polk (lead manager) |
| May 2026 | Newcleo | – | – | Placement | Announced | 220.0 | Nuclear energy+2 | BTIG (lead manager)Guggenheim Securities (issuer)Goldman Sachs (lead manager)Latham & Watkins (lead manager) |
| Apr 2026 | X-Energy | – | – | IPO | Announced | 1,017.9 | Nuclear energy+1 | Latham & Watkins (issuer)J.P. Morgan (lead manager)Morgan Stanley (lead manager)Jefferies (lead manager)Moelis & Company (lead manager)Cantor Fitzgerald (lead manager)UBS (lead manager)TD Securities (lead manager)Guggenheim Securities (lead manager)Nomura (lead manager)WR Securities (lead manager)Skadden, Arps, Slate, Meagher & Flom (lead manager) |
| Apr 2026 | Ionetix Corp. | – | – | Placement | Completed | 30.0 | Radiopharmaceuticals+1 | |
| Feb 2026 | Deep Fission | – | – | Placement | Completed | 80.0 | Nuclear energy+1 | Goldman Sachs (issuer)Seaport Global Securities (lead manager)The Benchmark Company (lead manager) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built